Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $920.69 | A | |
| $16.97 | A | |
| $13.09 | A |